Catalyst Pharmaceuticals (CPRX) Cost of Revenue (2019 - 2026)
Catalyst Pharmaceuticals (CPRX) recorded Cost of Revenue of $14.48 million in Q1 2026, down 19.2% from $17.91 million a year earlier and down 44.5% from the prior quarter.
Powered by 
Analysis
Catalyst Pharmaceuticals (CPRX) Cost of Revenue (2019 - 2026) Analysis & Trends
On a TTM basis, Catalyst Pharmaceuticals' Cost of Revenue came in at $83.82 million as of Mar 31, 2026, up 12.9% year-over-year; for FY2025, it was $87.25 million, up 26.7% from FY2024.
- Annual Cost of Revenue has increased for six straight years, with a five-year compound annual growth rate of 38.6% (FY2020 to FY2025).
- Across earlier years, Cost of Revenue came in at $68.85 million in FY2024 (+32.5%), $51.97 million in FY2023 (+51.1%), $34.39 million in FY2022 (+57.2%) and $21.88 million in FY2021 (+28.4%).
- The Q1 2026 figure is the lowest quarterly Cost of Revenue since Q1 2024.
- On a year-over-year basis, Cost of Revenue rose in seven of the last eight quarters, with growth averaging 24.6%.
- Peak year-over-year performance for Cost of Revenue in the last five years was growth of 82.0% in Q3 2022, against a decline of 19.2% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $26.07 million (Q4 2025), $22.65 million (Q3 2025) and $20.61 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 1.04 Bn | 134.92 Mn | 14.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 14.48 Mn |
| Dec 31, 2025 | 26.07 Mn |
| Sep 30, 2025 | 22.65 Mn |
| Jun 30, 2025 | 20.61 Mn |
| Mar 31, 2025 | 17.91 Mn |
| Dec 31, 2024 | 21.64 Mn |
| Sep 30, 2024 | 19.28 Mn |
| Jun 30, 2024 | 15.41 Mn |
| Mar 31, 2024 | 12.52 Mn |
| Dec 31, 2023 | 15.81 Mn |
| Sep 30, 2023 | 14.17 Mn |
| Jun 30, 2023 | 12.05 Mn |
| Mar 31, 2023 | 9.95 Mn |
| Dec 31, 2022 | 11.20 Mn |
| Sep 30, 2022 | 9.67 Mn |
| Jun 30, 2022 | 7.64 Mn |
| Mar 31, 2022 | 5.89 Mn |
| Dec 31, 2021 | 7.35 Mn |
| Sep 30, 2021 | 5.31 Mn |
| Jun 30, 2021 | 4.55 Mn |
API Access
Catalyst Pharmaceuticals Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=CPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "CPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=CPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();